Clinical characteristics and treatment outcomes of germ cell tumor in Jordan: A tertiary center experience

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  P. Warde,et al.  Discrepancy in pathology reports upon second review of radical orchiectomy specimens for testicular germ cell tumors. , 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[3]  J. Ferlay,et al.  International Trends in the Incidence of Testicular Cancer: Lessons from 35 Years and 41 Countries. , 2019, European urology.

[4]  D. Grignon,et al.  Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens. , 2017, Urologic oncology.

[5]  U. Demirci,et al.  Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors , 2017, World Journal of Urology.

[6]  F. Bray,et al.  International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973–2007 , 2015, Andrology.

[7]  Y. Homma,et al.  Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large‐scale study from the Cancer Registration Committee of the Japanese Urological Association , 2014, International journal of urology : official journal of the Japanese Urological Association.

[8]  H. Brenner,et al.  Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age. , 2013, Cancer epidemiology.

[9]  H. Errihani,et al.  Spermatocytic seminoma at the National Institute of Oncology in Morocco , 2011, BMC Research Notes.

[10]  J. Coebergh,et al.  Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study. , 2007, European journal of cancer.

[11]  M. Hentrich,et al.  Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich , 2005, Acta oncologica.

[12]  H. Adami,et al.  Testicular cancer incidence in eight northern European countries: secular and recent trends. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  M. Coleman,et al.  EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  M. Pike,et al.  Risk of testicular cancer in cohort of boys with cryptorchidism , 1997, BMJ.

[15]  J. A. Cabrera,et al.  Clinical presentation features of testicular cancer in public hospitals in the Autonomous Community of Madrid, Spain. , 2015, Actas urologicas espanolas.

[16]  K. Dieckmann,et al.  Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing. , 2014, Urologic oncology.

[17]  R. Amato,et al.  Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. , 2004, Urology.

[18]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .